Cell and Gene Therapy

Today’s breakthroughs can’t use yesterday’s solutions.

Cell and gene therapies that are creating new possibilities for patients deserve commercialization strategies that are just as pioneering.

AmerisourceBergen understands that new therapies demand a supply chain that’s willing to evolve. With businesses at the forefront of each commercialization touch point – and a history of supporting the launch of nearly every single biologic and specialty pharmaceutical product that has entered the market over the past 20 years – AmerisourceBergen is the trusted partner for cell and gene therapy innovators. From specialty logistics and market access consulting to patient support and the analysis of health outcomes, AmerisourceBergen provides the solutions that help your therapy fulfill its promise.
A group of seniors laugh together

Start a conversation

Looking for third-party logistics solutions that improve supply chain efficiencies and maximize commercialization success? Contact us to learn more.
Work with us